Fewer men in the United States are using testosterone replacement therapy following a stark decrease from 2013 to 2016 over concerns with over-prescribing and health risks, according to researchers with the University of Texas Medical Branch at Galveston. Testosterone treatments, including AbbVie’s Androgel, were heavily touted by drug companies as cure-alls for so-called Low T, a contrived condition caused by an age-related drop in testosterone levels that leads to symptoms such as low sex drive, weight gain, muscle loss and fatigue. The ad campaign resulted in hundreds of thousands of prescriptions for the male hormone supplement. Testosterone replacement therapies are ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.